Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.37
0.31 (6.13%)
At close: Jun 17, 2025, 3:09 PM
Silence Therapeutics Revenue
Silence Therapeutics reported an annual revenue of $43.26M, reflecting a 70.47% growth. For the quarter ending March 31, 2025, Silence Therapeutics generated $142K in revenue.
Revenue (ttm)
$43.26M
Revenue Growth
70.47%
Price / Sales Ratio
7.51
Revenue / Employee
$372.91K
Employees
116
Market Cap
253.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|